Skip to content

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Budget-Efficient PID Tuning of a Line-Following Differential-Drive AGV Using Extra Trees Surrogate-Assisted CMA-ES

Physical PID tuning for line-following automated guided vehicles (AGVs) is sample-inefficient because the gain-to-performance relationship is nonlinear and noisy, while every candidate must be executed on the real platform. Conventional population optimizers can therefore spend a limited experimental budget on unproduc...

Mastang, B. Taha, Retna Apsari et al. · 0 citations
Review Oct 2026

Self-adaptive nanophotonic metasurfaces enabling digital twins: toward continuous personalized healthcare in aging and disability.

Continuous physiological monitoring is a prerequisite in medicine that enables early disease detection, long-term health monitoring, and individualized therapeutic interventions. Although wearable optical biosensors have evolved significantly, their long-term clinical deployment remains limited by mechanical degradatio...

B. Taha, Ali J. Addie, K. Ibnaouf et al. · 0 citations
#gene editing Review Sep 2026

Light-activated CRISPR/dCas9 nanomedicine for programmable control of renal fibrosis.

It is argued that the most defensible therapeutic objective is not permanent genome editing or autonomous organ regeneration, but spatially confined, temporally limited, and reversible regulation of validated fibrotic or protective gene programs using CRISPRa, CRISPRi, or dCas9-based epigenome editors.

B. Taha, Ali J. Addie, A. Haider et al. · 1 citation
Review Jul 2026

Reversing cancer cell behavior using AI-guided CRISPR and quantum nanobiology: a systems-based approach to epigenetic reprogramming.

It is hypothesized that selected homeostatic gene-expression states may be partially restored in experimental cancer models through the integration of quantum-informed AI, CRISPR gene alteration, and nanomaterial delivery, which could support future cancer therapies that move beyond tumor suppression toward controlled...

B. Taha, Ali J. Addie, A. Haider et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.